Insider Transactions in Q1 2025 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Cecilia Jones Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,275
-4.38%
|
$79,625
$35.54 P/Share
|
|
Mar 03
2025
|
James William Burns Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,005
-5.73%
|
$140,175
$35.54 P/Share
|
|
Mar 03
2025
|
Brian Goff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,947
-6.73%
|
$453,145
$35.54 P/Share
|
|
Mar 03
2025
|
Tsveta Milanova Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,681
-6.84%
|
$58,835
$35.54 P/Share
|
|
Mar 03
2025
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,655
-6.39%
|
$57,925
$35.54 P/Share
|
|
Mar 03
2025
|
Sarah Gheuens Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,005
-2.57%
|
$140,175
$35.54 P/Share
|
|
Mar 01
2025
|
Cecilia Jones Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,667
+12.63%
|
-
|
|
Mar 01
2025
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+16.17%
|
-
|
|
Mar 01
2025
|
Brian Goff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,500
+11.99%
|
-
|
|
Mar 01
2025
|
Tsveta Milanova Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,667
+18.74%
|
-
|
|
Mar 01
2025
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,577
+17.46%
|
-
|
|
Mar 01
2025
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+7.96%
|
-
|
|
Feb 05
2025
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,272
-29.47%
|
$77,248
$34.39 P/Share
|
|
Feb 01
2025
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,896
+47.22%
|
-
|
|
Jan 06
2025
|
Tsveta Milanova Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,804
-12.92%
|
$89,728
$32.18 P/Share
|
|
Jan 03
2025
|
Tsveta Milanova Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,476
+28.08%
|
-
|